Cannabix Technologies Inc BLOZF

Primary Symbol: C.BLO

Cannabix Technologies Inc. is a Canada-based developer of marijuana and alcohol breath testing devices. The Company’s primary business is the development of marijuana breathalyzer technology. It is developing technologies to detect Tetrahydrocannabinol (THC) in breath samples for law enforcement, employers and laboratories. In addition, it is developing non-contact alcohol screening devices targeted primarily for workplace settings. The MS Breath Sampler (MSBS) is specialized laboratory hardware developed by the Company to confirm THC in breath from humans. The MSBS is a method for collection of analytes of low volatility from human breath utilizing liquid secondary adsorption. Within the Breath Collection Unit (THC detection), the sample is captured inside a cartridge and loaded into the MSBS. In preliminary testing, the system has detected and confirmed THC in breath out to four hours after smoking with breath samples being stored and analyzed up to two days after sample collection.

CSE:BLO - Post by User

Cannabix Technologies Inc > New Press Release - Cannabix Technologies Welcomes Dr. Phillip Olla to the Board of Directors

<< Previous

Bullboard Posts

Next >>

Comment by monte8on Apr 02, 2024 10:38am

103 Views

Post# 35965051

RE:New Press Release - Cannabix Technologies Welcomes Dr. Phillip Olla to the Board of Directors

Dr. Phillip Olla has a respectable resume, a global speaker and connected in this field.

Rav Mlait, CEO, stated, “Dr. Olla's expertise in multi-modal breath analysis will aid in advancing Cannabix’s marijuana and alcohol breathalyzer technologies in the U.S. and Europe. Dr. Olla has amassed a considerable network of industry professionals and experience that will help Cannabix move to commercialization. Dr. Olla will also help explore additional applications and market.
opportunities for Cannabix’s novel breath testing technologies.”

I think this is great news as he will help to bring the product to market.

Though, the issuance and granting a total of 2.7M incentive stock options to directors and consultants of the Company wasn't all that great of news, especially issuing at such a low exercisable per share price($0.25). Come on man!!!

Just goes to show you they give a little but take alot!!!

<< Previous

Bullboard Posts

Next >>

Fobi AI could address a market in the trillions: Why it's time to buy